Trial Profile
Evaluation of the safety of intra-nasal administration of oxytocin in infants with Prader-Willi syndrome and its effect on suction and food intake.
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2017
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Prader-Willi syndrome
- Focus Adverse reactions
- 05 Oct 2017 New trial record